APO Research
Talk to an analyst

APO RESEARCH · REPORT

Serum and Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Serum and Plasma Proteomics Service Market Outlook and Growth Opportunities 2026

12 August 2026213 pages

Choose your research edition.

Industry ResearchSerum and Plasma Proteomics Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Serum and Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Serum and Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Serum and Plasma Proteomics Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Serum and Plasma Proteomics Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Serum and Plasma Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Serum and Plasma Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Serum and Plasma Proteomics Service market include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Serum and Plasma Proteomics Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Serum and Plasma Proteomics Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Serum and Plasma Proteomics Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Serum and Plasma Proteomics Service market.

Serum and Plasma Proteomics Service Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Serum and Plasma Proteomics Service Segment by Type

Plasma Proteomics Analysis Service

Serum Proteomics Analysis Service

Serum and Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Serum and Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Serum and Plasma Proteomics Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Serum and Plasma Proteomics Service key companies, revenue, market share, and recent developments.

3. To split the Serum and Plasma Proteomics Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Serum and Plasma Proteomics Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Serum and Plasma Proteomics Service significant trends, drivers, influence factors in global and regions.

6. To analyze Serum and Plasma Proteomics Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum and Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Serum and Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum and Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Serum and Plasma Proteomics Service industry.

Chapter 3: Detailed analysis of Serum and Plasma Proteomics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Serum and Plasma Proteomics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Serum and Plasma Proteomics Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Serum and Plasma Proteomics Service Industry Trends Table 2. Serum and Plasma Proteomics Service Industry Drivers Table 3. Serum and Plasma Proteomics Service Industry Opportunities and Challenges Table 4. Serum and Plasma Proteomics Service Industry Restraints Table 5. Global Serum and Plasma Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Serum and Plasma Proteomics Service Revenue Share by Company (2021-2026) Table 7. Global Serum and Plasma Proteomics Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Serum and Plasma Proteomics Service Key Company Manufacturing Base & Headquarters Table 9. Global Serum and Plasma Proteomics Service Company, Product Type & Application Table 10. Global Serum and Plasma Proteomics Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Serum and Plasma Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plasma Proteomics Analysis Service Table 15. Significant Companies of Serum Proteomics Analysis Service Table 16. Global Serum and Plasma Proteomics Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Serum and Plasma Proteomics Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Serum and Plasma Proteomics Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Serum and Plasma Proteomics Service Sales Value Share by Type (2021-2026) Table 20. Global Serum and Plasma Proteomics Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Disease Biomarker Research Table 22. Significant Companies of Drug Development Table 23. Significant Companies of Clinical Research Table 24. Significant Companies of Others Table 25. Global Serum and Plasma Proteomics Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Serum and Plasma Proteomics Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Serum and Plasma Proteomics Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Serum and Plasma Proteomics Service Sales Value Share by Application (2021-2026) Table 29. Global Serum and Plasma Proteomics Service Sales Value Share by Application (2027-2032) Table 30. Global Serum and Plasma Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Serum and Plasma Proteomics Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Serum and Plasma Proteomics Service Sales Value Share by Region (2021-2026) Table 33. Global Serum and Plasma Proteomics Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Serum and Plasma Proteomics Service Sales Value Share by Region (2027-2032) Table 35. Global Serum and Plasma Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Serum and Plasma Proteomics Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Serum and Plasma Proteomics Service Sales Value Market Share by Country (2021-2026) Table 38. Global Serum and Plasma Proteomics Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Serum and Plasma Proteomics Service Sales Value Market Share by Country (2027-2032) Table 40. BostonGene Company Information Table 41. BostonGene Business Overview Table 42. BostonGene Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. BostonGene Serum and Plasma Proteomics Service Product Portfolio Table 44. BostonGene Recent Development Table 45. CellCarta Company Information Table 46. CellCarta Business Overview Table 47. CellCarta Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. CellCarta Serum and Plasma Proteomics Service Product Portfolio Table 49. CellCarta Recent Development Table 50. GENEWIZ (Azenta Life Sciences) Company Information Table 51. GENEWIZ (Azenta Life Sciences) Business Overview Table 52. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio Table 54. GENEWIZ (Azenta Life Sciences) Recent Development Table 55. CDI Labs Company Information Table 56. CDI Labs Business Overview Table 57. CDI Labs Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. CDI Labs Serum and Plasma Proteomics Service Product Portfolio Table 59. CDI Labs Recent Development Table 60. Biognosys Company Information Table 61. Biognosys Business Overview Table 62. Biognosys Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Biognosys Serum and Plasma Proteomics Service Product Portfolio Table 64. Biognosys Recent Development Table 65. Discovery Life Sciences Company Information Table 66. Discovery Life Sciences Business Overview Table 67. Discovery Life Sciences Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio Table 69. Discovery Life Sciences Recent Development Table 70. Firalis Molecular Precision Company Information Table 71. Firalis Molecular Precision Business Overview Table 72. Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio Table 74. Firalis Molecular Precision Recent Development Table 75. Cell Signaling Technology (CST) Company Information Table 76. Cell Signaling Technology (CST) Business Overview Table 77. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio Table 79. Cell Signaling Technology (CST) Recent Development Table 80. Sampled (Infinity Biologix) Company Information Table 81. Sampled (Infinity Biologix) Business Overview Table 82. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio Table 84. Sampled (Infinity Biologix) Recent Development Table 85. APTBIO Company Information Table 86. APTBIO Business Overview Table 87. APTBIO Serum and Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. APTBIO Serum and Plasma Proteomics Service Product Portfolio Table 89. APTBIO Recent Development Table 90. Sinotech Genomics Company Information Table 91. Sinotech Genomics Business Overview Table 92. Sinotech Genomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio Table 94. Sinotech Genomics Recent Development Table 95. Biodesix Company Information Table 96. Biodesix Business Overview Table 97. Biodesix Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Biodesix Serum and Plasma Proteomics Service Product Portfolio Table 99. Biodesix Recent Development Table 100. Panome Bio Company Information Table 101. Panome Bio Business Overview Table 102. Panome Bio Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Panome Bio Serum and Plasma Proteomics Service Product Portfolio Table 104. Panome Bio Recent Development Table 105. Novogene Company Information Table 106. Novogene Business Overview Table 107. Novogene Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Novogene Serum and Plasma Proteomics Service Product Portfolio Table 109. Novogene Recent Development Table 110. PTM BIO Company Information Table 111. PTM BIO Business Overview Table 112. PTM BIO Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. PTM BIO Serum and Plasma Proteomics Service Product Portfolio Table 114. PTM BIO Recent Development Table 115. BGI Genomics Company Information Table 116. BGI Genomics Business Overview Table 117. BGI Genomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. BGI Genomics Serum and Plasma Proteomics Service Product Portfolio Table 119. BGI Genomics Recent Development Table 120. Evotec Company Information Table 121. Evotec Business Overview Table 122. Evotec Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Evotec Serum and Plasma Proteomics Service Product Portfolio Table 124. Evotec Recent Development Table 125. Metware Biotechnology Company Information Table 126. Metware Biotechnology Business Overview Table 127. Metware Biotechnology Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio Table 129. Metware Biotechnology Recent Development Table 130. MRM Proteomics Company Information Table 131. MRM Proteomics Business Overview Table 132. MRM Proteomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 134. MRM Proteomics Recent Development Table 135. Lc-Bio Technologies Company Information Table 136. Lc-Bio Technologies Business Overview Table 137. Lc-Bio Technologies Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio Table 139. Lc-Bio Technologies Recent Development Table 140. Eurofins Scientific Company Information Table 141. Eurofins Scientific Business Overview Table 142. Eurofins Scientific Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio Table 144. Eurofins Scientific Recent Development Table 145. MtoZ-Biolabs Company Information Table 146. MtoZ-Biolabs Business Overview Table 147. MtoZ-Biolabs Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio Table 149. MtoZ-Biolabs Recent Development Table 150. Creative Proteomics Company Information Table 151. Creative Proteomics Business Overview Table 152. Creative Proteomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 154. Creative Proteomics Recent Development Table 155. Macrogen Company Information Table 156. Macrogen Business Overview Table 157. Macrogen Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Macrogen Serum and Plasma Proteomics Service Product Portfolio Table 159. Macrogen Recent Development Table 160. TATAA Biocenter Company Information Table 161. TATAA Biocenter Business Overview Table 162. TATAA Biocenter Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio Table 164. TATAA Biocenter Recent Development Table 165. OmicScouts (Momentum Biotechnologies) Company Information Table 166. OmicScouts (Momentum Biotechnologies) Business Overview Table 167. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio Table 169. OmicScouts (Momentum Biotechnologies) Recent Development Table 170. Precision Biomarker Laboratories (PBL) Company Information Table 171. Precision Biomarker Laboratories (PBL) Business Overview Table 172. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio Table 174. Precision Biomarker Laboratories (PBL) Recent Development Table 175. Shanghai OE Biotech Company Information Table 176. Shanghai OE Biotech Business Overview Table 177. Shanghai OE Biotech Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio Table 179. Shanghai OE Biotech Recent Development Table 180. RxCelerate Company Information Table 181. RxCelerate Business Overview Table 182. RxCelerate Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. RxCelerate Serum and Plasma Proteomics Service Product Portfolio Table 184. RxCelerate Recent Development Table 185. Proteomics International Company Information Table 186. Proteomics International Business Overview Table 187. Proteomics International Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 188. Proteomics International Serum and Plasma Proteomics Service Product Portfolio Table 189. Proteomics International Recent Development Table 190. Proteome Sciences Company Information Table 191. Proteome Sciences Business Overview Table 192. Proteome Sciences Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 193. Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio Table 194. Proteome Sciences Recent Development Table 195. Westlake Omics Company Information Table 196. Westlake Omics Business Overview Table 197. Westlake Omics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 198. Westlake Omics Serum and Plasma Proteomics Service Product Portfolio Table 199. Westlake Omics Recent Development Table 200. Crown Bioscience Company Information Table 201. Crown Bioscience Business Overview Table 202. Crown Bioscience Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 203. Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio Table 204. Crown Bioscience Recent Development Table 205. VProteomics Company Information Table 206. VProteomics Business Overview Table 207. VProteomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 208. VProteomics Serum and Plasma Proteomics Service Product Portfolio Table 209. VProteomics Recent Development Table 210. Shanghai Majorbio Bio-Pharm Company Information Table 211. Shanghai Majorbio Bio-Pharm Business Overview Table 212. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 213. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio Table 214. Shanghai Majorbio Bio-Pharm Recent Development Table 215. Applied Biomics Company Information Table 216. Applied Biomics Business Overview Table 217. Applied Biomics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 218. Applied Biomics Serum and Plasma Proteomics Service Product Portfolio Table 219. Applied Biomics Recent Development Table 220. Sapient Bioanalytics Company Information Table 221. Sapient Bioanalytics Business Overview Table 222. Sapient Bioanalytics Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 223. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio Table 224. Sapient Bioanalytics Recent Development Table 225. Allumiqs Company Information Table 226. Allumiqs Business Overview Table 227. Allumiqs Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 228. Allumiqs Serum and Plasma Proteomics Service Product Portfolio Table 229. Allumiqs Recent Development Table 230. MS Bioworks Company Information Table 231. MS Bioworks Business Overview Table 232. MS Bioworks Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 233. MS Bioworks Serum and Plasma Proteomics Service Product Portfolio Table 234. MS Bioworks Recent Development Table 235. Shanghai Bioprofile Company Information Table 236. Shanghai Bioprofile Business Overview Table 237. Shanghai Bioprofile Serum and Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 238. Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio Table 239. Shanghai Bioprofile Recent Development Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Serum and Plasma Proteomics Service Product Image Figure 2. Global Serum and Plasma Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Serum and Plasma Proteomics Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plasma Proteomics Analysis Service Image Figure 8. Serum Proteomics Analysis Service Image Figure 9. Global Serum and Plasma Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Serum and Plasma Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Serum and Plasma Proteomics Service Sales Value Share by Type (2021-2032) Figure 12. Disease Biomarker Research Image Figure 13. Drug Development Image Figure 14. Clinical Research Image Figure 15. Others Image Figure 16. Global Serum and Plasma Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Serum and Plasma Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Serum and Plasma Proteomics Service Sales Value Share by Application (2021-2032) Figure 19. Global Serum and Plasma Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Serum and Plasma Proteomics Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Serum and Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Serum and Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Serum and Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Serum and Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Serum and Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Serum and Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Serum and Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Serum and Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Serum and Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Serum and Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Proteomics Analysis Service
  • Serum Proteomics Analysis Service
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Serum and Plasma Proteomics Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Serum and Plasma Proteomics Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Serum and Plasma Proteomics Service Market Dynamics
  1. 2.1 Serum and Plasma Proteomics Service Industry Trends
  2. 2.2 Serum and Plasma Proteomics Service Industry Drivers
  3. 2.3 Serum and Plasma Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Serum and Plasma Proteomics Service Industry Restraints
3 Serum and Plasma Proteomics Service Market by Company
  1. 3.1 Global Serum and Plasma Proteomics Service Company Revenue Ranking in 2025
  2. 3.2 Global Serum and Plasma Proteomics Service Revenue by Company (2021-2026)
  3. 3.3 Global Serum and Plasma Proteomics Service Company Ranking (2024-2026)
  4. 3.4 Global Serum and Plasma Proteomics Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Serum and Plasma Proteomics Service Company Product Type and Application
  6. 3.6 Global Serum and Plasma Proteomics Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Serum and Plasma Proteomics Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Serum and Plasma Proteomics Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Serum and Plasma Proteomics Service Market by Type
  1. 4.1 Serum and Plasma Proteomics Service Type Introduction
  2. 4.1.1 Plasma Proteomics Analysis Service
  3. 4.1.2 Serum Proteomics Analysis Service
  4. 4.2 Global Serum and Plasma Proteomics Service Sales Value by Type
  5. 4.2.1 Global Serum and Plasma Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Serum and Plasma Proteomics Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Serum and Plasma Proteomics Service Sales Value Share by Type (2021-2032)
5 Serum and Plasma Proteomics Service Market by Application
  1. 5.1 Serum and Plasma Proteomics Service Application Introduction
  2. 5.1.1 Disease Biomarker Research
  3. 5.1.2 Drug Development
  4. 5.1.3 Clinical Research
  5. 5.1.4 Others
  6. 5.2 Global Serum and Plasma Proteomics Service Sales Value by Application
  7. 5.2.1 Global Serum and Plasma Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Serum and Plasma Proteomics Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Serum and Plasma Proteomics Service Sales Value Share by Application (2021-2032)
6 Serum and Plasma Proteomics Service Regional Value Analysis
  1. 6.1 Global Serum and Plasma Proteomics Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Serum and Plasma Proteomics Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Serum and Plasma Proteomics Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Serum and Plasma Proteomics Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Serum and Plasma Proteomics Service Sales Value (2021-2032)
  7. 6.3.2 North America Serum and Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Serum and Plasma Proteomics Service Sales Value (2021-2032)
  10. 6.4.2 Europe Serum and Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Serum and Plasma Proteomics Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Serum and Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Serum and Plasma Proteomics Service Sales Value (2021-2032)
  16. 6.6.2 South America Serum and Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Serum and Plasma Proteomics Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Serum and Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
7 Serum and Plasma Proteomics Service Country-level Value Analysis
  1. 7.1 Global Serum and Plasma Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Serum and Plasma Proteomics Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Serum and Plasma Proteomics Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Serum and Plasma Proteomics Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Serum and Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Serum and Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Serum and Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BostonGene
  2. 8.1.1 BostonGene Company Information
  3. 8.1.2 BostonGene Business Overview
  4. 8.1.3 BostonGene Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BostonGene Serum and Plasma Proteomics Service Product Portfolio
  6. 8.1.5 BostonGene Recent Developments
  7. 8.2 CellCarta
  8. 8.2.1 CellCarta Company Information
  9. 8.2.2 CellCarta Business Overview
  10. 8.2.3 CellCarta Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CellCarta Serum and Plasma Proteomics Service Product Portfolio
  12. 8.2.5 CellCarta Recent Developments
  13. 8.3 GENEWIZ (Azenta Life Sciences)
  14. 8.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 8.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 8.3.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio
  18. 8.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 8.4 CDI Labs
  20. 8.4.1 CDI Labs Company Information
  21. 8.4.2 CDI Labs Business Overview
  22. 8.4.3 CDI Labs Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CDI Labs Serum and Plasma Proteomics Service Product Portfolio
  24. 8.4.5 CDI Labs Recent Developments
  25. 8.5 Biognosys
  26. 8.5.1 Biognosys Company Information
  27. 8.5.2 Biognosys Business Overview
  28. 8.5.3 Biognosys Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biognosys Serum and Plasma Proteomics Service Product Portfolio
  30. 8.5.5 Biognosys Recent Developments
  31. 8.6 Discovery Life Sciences
  32. 8.6.1 Discovery Life Sciences Company Information
  33. 8.6.2 Discovery Life Sciences Business Overview
  34. 8.6.3 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio
  36. 8.6.5 Discovery Life Sciences Recent Developments
  37. 8.7 Firalis Molecular Precision
  38. 8.7.1 Firalis Molecular Precision Company Information
  39. 8.7.2 Firalis Molecular Precision Business Overview
  40. 8.7.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio
  42. 8.7.5 Firalis Molecular Precision Recent Developments
  43. 8.8 Cell Signaling Technology (CST)
  44. 8.8.1 Cell Signaling Technology (CST) Company Information
  45. 8.8.2 Cell Signaling Technology (CST) Business Overview
  46. 8.8.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio
  48. 8.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 8.9 Sampled (Infinity Biologix)
  50. 8.9.1 Sampled (Infinity Biologix) Company Information
  51. 8.9.2 Sampled (Infinity Biologix) Business Overview
  52. 8.9.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio
  54. 8.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 8.10 APTBIO
  56. 8.10.1 APTBIO Company Information
  57. 8.10.2 APTBIO Business Overview
  58. 8.10.3 APTBIO Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 APTBIO Serum and Plasma Proteomics Service Product Portfolio
  60. 8.10.5 APTBIO Recent Developments
  61. 8.11 Sinotech Genomics
  62. 8.11.1 Sinotech Genomics Company Information
  63. 8.11.2 Sinotech Genomics Business Overview
  64. 8.11.3 Sinotech Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio
  66. 8.11.5 Sinotech Genomics Recent Developments
  67. 8.12 Biodesix
  68. 8.12.1 Biodesix Company Information
  69. 8.12.2 Biodesix Business Overview
  70. 8.12.3 Biodesix Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biodesix Serum and Plasma Proteomics Service Product Portfolio
  72. 8.12.5 Biodesix Recent Developments
  73. 8.13 Panome Bio
  74. 8.13.1 Panome Bio Company Information
  75. 8.13.2 Panome Bio Business Overview
  76. 8.13.3 Panome Bio Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Panome Bio Serum and Plasma Proteomics Service Product Portfolio
  78. 8.13.5 Panome Bio Recent Developments
  79. 8.14 Novogene
  80. 8.14.1 Novogene Company Information
  81. 8.14.2 Novogene Business Overview
  82. 8.14.3 Novogene Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novogene Serum and Plasma Proteomics Service Product Portfolio
  84. 8.14.5 Novogene Recent Developments
  85. 8.15 PTM BIO
  86. 8.15.1 PTM BIO Company Information
  87. 8.15.2 PTM BIO Business Overview
  88. 8.15.3 PTM BIO Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PTM BIO Serum and Plasma Proteomics Service Product Portfolio
  90. 8.15.5 PTM BIO Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Serum and Plasma Proteomics Service Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 Evotec
  98. 8.17.1 Evotec Company Information
  99. 8.17.2 Evotec Business Overview
  100. 8.17.3 Evotec Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Evotec Serum and Plasma Proteomics Service Product Portfolio
  102. 8.17.5 Evotec Recent Developments
  103. 8.18 Metware Biotechnology
  104. 8.18.1 Metware Biotechnology Company Information
  105. 8.18.2 Metware Biotechnology Business Overview
  106. 8.18.3 Metware Biotechnology Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio
  108. 8.18.5 Metware Biotechnology Recent Developments
  109. 8.19 MRM Proteomics
  110. 8.19.1 MRM Proteomics Company Information
  111. 8.19.2 MRM Proteomics Business Overview
  112. 8.19.3 MRM Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio
  114. 8.19.5 MRM Proteomics Recent Developments
  115. 8.20 Lc-Bio Technologies
  116. 8.20.1 Lc-Bio Technologies Company Information
  117. 8.20.2 Lc-Bio Technologies Business Overview
  118. 8.20.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio
  120. 8.20.5 Lc-Bio Technologies Recent Developments
  121. 8.21 Eurofins Scientific
  122. 8.21.1 Eurofins Scientific Company Information
  123. 8.21.2 Eurofins Scientific Business Overview
  124. 8.21.3 Eurofins Scientific Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio
  126. 8.21.5 Eurofins Scientific Recent Developments
  127. 8.22 MtoZ-Biolabs
  128. 8.22.1 MtoZ-Biolabs Company Information
  129. 8.22.2 MtoZ-Biolabs Business Overview
  130. 8.22.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio
  132. 8.22.5 MtoZ-Biolabs Recent Developments
  133. 8.23 Creative Proteomics
  134. 8.23.1 Creative Proteomics Company Information
  135. 8.23.2 Creative Proteomics Business Overview
  136. 8.23.3 Creative Proteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio
  138. 8.23.5 Creative Proteomics Recent Developments
  139. 8.24 Macrogen
  140. 8.24.1 Macrogen Company Information
  141. 8.24.2 Macrogen Business Overview
  142. 8.24.3 Macrogen Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Macrogen Serum and Plasma Proteomics Service Product Portfolio
  144. 8.24.5 Macrogen Recent Developments
  145. 8.25 TATAA Biocenter
  146. 8.25.1 TATAA Biocenter Company Information
  147. 8.25.2 TATAA Biocenter Business Overview
  148. 8.25.3 TATAA Biocenter Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio
  150. 8.25.5 TATAA Biocenter Recent Developments
  151. 8.26 OmicScouts (Momentum Biotechnologies)
  152. 8.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 8.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 8.26.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  155. 8.26.4 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio
  156. 8.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 8.27 Precision Biomarker Laboratories (PBL)
  158. 8.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 8.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 8.27.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio
  162. 8.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 8.28 Shanghai OE Biotech
  164. 8.28.1 Shanghai OE Biotech Company Information
  165. 8.28.2 Shanghai OE Biotech Business Overview
  166. 8.28.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio
  168. 8.28.5 Shanghai OE Biotech Recent Developments
  169. 8.29 RxCelerate
  170. 8.29.1 RxCelerate Company Information
  171. 8.29.2 RxCelerate Business Overview
  172. 8.29.3 RxCelerate Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  173. 8.29.4 RxCelerate Serum and Plasma Proteomics Service Product Portfolio
  174. 8.29.5 RxCelerate Recent Developments
  175. 8.30 Proteomics International
  176. 8.30.1 Proteomics International Company Information
  177. 8.30.2 Proteomics International Business Overview
  178. 8.30.3 Proteomics International Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Proteomics International Serum and Plasma Proteomics Service Product Portfolio
  180. 8.30.5 Proteomics International Recent Developments
  181. 8.31 Proteome Sciences
  182. 8.31.1 Proteome Sciences Company Information
  183. 8.31.2 Proteome Sciences Business Overview
  184. 8.31.3 Proteome Sciences Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio
  186. 8.31.5 Proteome Sciences Recent Developments
  187. 8.32 Westlake Omics
  188. 8.32.1 Westlake Omics Company Information
  189. 8.32.2 Westlake Omics Business Overview
  190. 8.32.3 Westlake Omics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Westlake Omics Serum and Plasma Proteomics Service Product Portfolio
  192. 8.32.5 Westlake Omics Recent Developments
  193. 8.33 Crown Bioscience
  194. 8.33.1 Crown Bioscience Company Information
  195. 8.33.2 Crown Bioscience Business Overview
  196. 8.33.3 Crown Bioscience Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio
  198. 8.33.5 Crown Bioscience Recent Developments
  199. 8.34 VProteomics
  200. 8.34.1 VProteomics Company Information
  201. 8.34.2 VProteomics Business Overview
  202. 8.34.3 VProteomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  203. 8.34.4 VProteomics Serum and Plasma Proteomics Service Product Portfolio
  204. 8.34.5 VProteomics Recent Developments
  205. 8.35 Shanghai Majorbio Bio-Pharm
  206. 8.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 8.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 8.35.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio
  210. 8.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 8.36 Applied Biomics
  212. 8.36.1 Applied Biomics Company Information
  213. 8.36.2 Applied Biomics Business Overview
  214. 8.36.3 Applied Biomics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Applied Biomics Serum and Plasma Proteomics Service Product Portfolio
  216. 8.36.5 Applied Biomics Recent Developments
  217. 8.37 Sapient Bioanalytics
  218. 8.37.1 Sapient Bioanalytics Company Information
  219. 8.37.2 Sapient Bioanalytics Business Overview
  220. 8.37.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio
  222. 8.37.5 Sapient Bioanalytics Recent Developments
  223. 8.38 Allumiqs
  224. 8.38.1 Allumiqs Company Information
  225. 8.38.2 Allumiqs Business Overview
  226. 8.38.3 Allumiqs Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Allumiqs Serum and Plasma Proteomics Service Product Portfolio
  228. 8.38.5 Allumiqs Recent Developments
  229. 8.39 MS Bioworks
  230. 8.39.1 MS Bioworks Company Information
  231. 8.39.2 MS Bioworks Business Overview
  232. 8.39.3 MS Bioworks Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  233. 8.39.4 MS Bioworks Serum and Plasma Proteomics Service Product Portfolio
  234. 8.39.5 MS Bioworks Recent Developments
  235. 8.40 Shanghai Bioprofile
  236. 8.40.1 Shanghai Bioprofile Company Information
  237. 8.40.2 Shanghai Bioprofile Business Overview
  238. 8.40.3 Shanghai Bioprofile Serum and Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio
  240. 8.40.5 Shanghai Bioprofile Recent Developments
  241. 8.41 Cosmos Wisdom
  242. 8.42 Olink (Thermo Fisher Scientific)
  243. 8.43 SomaLogic (Illumina)
  244. 8.44 Labcorp
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst